Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.27 Million USD | 20.3% |
| 2022 | 4.33 Million USD | 123.22% |
| 2021 | 1.94 Million USD | 286.29% |
| 2020 | 502.34 Thousand USD | -88.36% |
| 2019 | 4.31 Million USD | 30.16% |
| 2018 | 3.31 Million USD | 24.15% |
| 2017 | 2.67 Million USD | 237.81% |
| 2016 | 790.88 Thousand USD | -77.14% |
| 2015 | 3.45 Million USD | -27.29% |
| 2014 | 4.75 Million USD | -19.9% |
| 2013 | 5.93 Million USD | 3.1% |
| 2012 | 5.76 Million USD | 53.71% |
| 2011 | 3.74 Million USD | 594.96% |
| 2010 | 539.32 Thousand USD | 1257.85% |
| 2009 | 39.71 Thousand USD | 177.97% |
| 2008 | 14.28 Thousand USD | -83.85% |
| 2007 | 88.5 Thousand USD | 637.5% |
| 2006 | 12 Thousand USD | 20.55% |
| 2005 | 9954.00 USD | -83.83% |
| 2004 | 61.54 Thousand USD | -81.57% |
| 2003 | 333.9 Thousand USD | 0.0% |
| 2001 | 850 Thousand USD | 112.5% |
| 2000 | 400 Thousand USD | -50.62% |
| 1999 | 810 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.64 Million USD | 5.9% |
| 2024 Q1 | 1.41 Million USD | -16.53% |
| 2023 Q2 | 1.53 Million USD | 25.21% |
| 2023 Q1 | 1.22 Million USD | 8.7% |
| 2023 FY | 5.21 Million USD | 20.3% |
| 2023 Q4 | 1.68 Million USD | 27.96% |
| 2023 Q3 | 1.32 Million USD | -13.92% |
| 2022 Q3 | 1.16 Million USD | 7.7% |
| 2022 FY | 4.33 Million USD | 123.22% |
| 2022 Q4 | 1.12 Million USD | -3.67% |
| 2022 Q2 | 1.08 Million USD | 14.54% |
| 2022 Q1 | 948.37 Thousand USD | -14.59% |
| 2021 Q1 | 52.01 Thousand USD | -53.61% |
| 2021 Q4 | 1.11 Million USD | 48.55% |
| 2021 FY | 1.94 Million USD | 286.29% |
| 2021 Q3 | 747.46 Thousand USD | 2341.59% |
| 2021 Q2 | 30.61 Thousand USD | -41.15% |
| 2020 FY | 502.34 Thousand USD | -88.36% |
| 2020 Q4 | 112.12 Thousand USD | -4.39% |
| 2020 Q3 | 117.27 Thousand USD | 18.71% |
| 2020 Q2 | 98.79 Thousand USD | -43.27% |
| 2020 Q1 | 174.14 Thousand USD | -7.79% |
| 2019 Q1 | 1.47 Million USD | 86.46% |
| 2019 Q4 | 188.85 Thousand USD | -83.7% |
| 2019 FY | 4.31 Million USD | 30.16% |
| 2019 Q2 | 1.49 Million USD | 1.14% |
| 2019 Q3 | 1.15 Million USD | -22.42% |
| 2018 Q3 | 1.19 Million USD | 50.56% |
| 2018 Q1 | 531.84 Thousand USD | -28.32% |
| 2018 Q2 | 795.46 Thousand USD | 49.57% |
| 2018 Q4 | 791.84 Thousand USD | -33.88% |
| 2018 FY | 3.31 Million USD | 24.15% |
| 2017 Q4 | 741.98 Thousand USD | 33.22% |
| 2017 FY | 2.67 Million USD | 237.81% |
| 2017 Q3 | 556.96 Thousand USD | 31.64% |
| 2017 Q2 | 423.09 Thousand USD | -55.45% |
| 2017 Q1 | 949.64 Thousand USD | 156.99% |
| 2016 Q2 | 903.7 Thousand USD | 33.88% |
| 2016 FY | 790.88 Thousand USD | -77.14% |
| 2016 Q4 | -1.66 Million USD | -289.68% |
| 2016 Q1 | 675 Thousand USD | -27.79% |
| 2016 Q3 | 878.5 Thousand USD | -2.79% |
| 2015 FY | 3.45 Million USD | -27.29% |
| 2015 Q2 | 829.33 Thousand USD | -15.79% |
| 2015 Q3 | 710.55 Thousand USD | -14.32% |
| 2015 Q4 | 934.75 Thousand USD | 31.55% |
| 2015 Q1 | 984.8 Thousand USD | -46.38% |
| 2014 Q2 | 1.18 Million USD | -18.1% |
| 2014 FY | 4.75 Million USD | -19.9% |
| 2014 Q4 | 1.83 Million USD | 85.44% |
| 2014 Q3 | 990.5 Thousand USD | -16.18% |
| 2014 Q1 | 1.44 Million USD | -12.55% |
| 2013 Q4 | 1.64 Million USD | 23.79% |
| 2013 Q3 | 1.33 Million USD | -13.39% |
| 2013 FY | 5.93 Million USD | 3.1% |
| 2013 Q1 | 1.48 Million USD | -3.58% |
| 2013 Q2 | 1.53 Million USD | 3.39% |
| 2012 Q3 | 1.48 Million USD | 0.94% |
| 2012 FY | 5.76 Million USD | 53.71% |
| 2012 Q4 | 1.54 Million USD | 4.25% |
| 2012 Q1 | 580.46 Thousand USD | -60.6% |
| 2012 Q2 | 1.46 Million USD | 152.76% |
| 2011 Q2 | 842.06 Thousand USD | 159.03% |
| 2011 Q4 | 1.47 Million USD | 33.0% |
| 2011 Q3 | 1.1 Million USD | 31.55% |
| 2011 Q1 | 325.08 Thousand USD | -1.43% |
| 2011 FY | 3.74 Million USD | 594.96% |
| 2010 FY | 539.32 Thousand USD | 1257.85% |
| 2010 Q4 | 329.78 Thousand USD | 264.93% |
| 2010 Q3 | 90.36 Thousand USD | -20.25% |
| 2010 Q2 | 113.31 Thousand USD | 1835.32% |
| 2010 Q1 | 5855.00 USD | -65.18% |
| 2009 Q3 | 13.77 Thousand USD | 109.34% |
| 2009 Q4 | 16.81 Thousand USD | 22.04% |
| 2009 Q1 | 2542.00 USD | -67.09% |
| 2009 FY | 39.71 Thousand USD | 177.97% |
| 2009 Q2 | 6582.00 USD | 158.93% |
| 2008 Q1 | 10 Thousand USD | 106.9% |
| 2008 Q3 | 22.52 Thousand USD | -13.34% |
| 2008 Q4 | 7725.00 USD | -65.7% |
| 2008 FY | 14.28 Thousand USD | -83.85% |
| 2008 Q2 | 25.98 Thousand USD | 159.88% |
| 2007 FY | 88.5 Thousand USD | 637.5% |
| 2007 Q3 | 15 Thousand USD | -90.32% |
| 2007 Q2 | 155 Thousand USD | 144.09% |
| 2007 Q1 | 63.5 Thousand USD | 6250.0% |
| 2007 Q4 | -145 Thousand USD | -1066.67% |
| 2006 Q2 | 1000.00 USD | -88.89% |
| 2006 Q1 | 9000.00 USD | 800.9% |
| 2006 FY | 12 Thousand USD | 20.55% |
| 2006 Q3 | 1000.00 USD | 0.0% |
| 2006 Q4 | 1000.00 USD | 0.0% |
| 2005 FY | 9954.00 USD | -83.83% |
| 2005 Q2 | 6722.00 USD | 521.26% |
| 2005 Q3 | 1151.00 USD | -82.88% |
| 2005 Q4 | 999.00 USD | -13.21% |
| 2005 Q1 | 1082.00 USD | -95.32% |
| 2004 Q4 | 23.13 Thousand USD | 164.48% |
| 2004 Q2 | 12.2 Thousand USD | -30.09% |
| 2004 Q3 | 8749.00 USD | -28.3% |
| 2004 Q1 | 17.45 Thousand USD | 256.01% |
| 2004 FY | 61.54 Thousand USD | -81.57% |
| 2003 FY | 333.9 Thousand USD | 0.0% |
| 2003 Q3 | 2000.00 USD | 0.0% |
| 2003 Q1 | 1000.00 USD | 0.0% |
| 2003 Q4 | 4903.00 USD | 145.15% |
| 2001 Q3 | 189.99 Thousand USD | 111.11% |
| 2001 Q4 | 429.99 Thousand USD | 126.32% |
| 2001 FY | 850 Thousand USD | 112.5% |
| 2001 Q2 | 89.99 Thousand USD | -40.0% |
| 2001 Q1 | 150 Thousand USD | 15.39% |
| 2000 FY | 400 Thousand USD | -50.62% |
| 2000 Q2 | 80 Thousand USD | 14.29% |
| 2000 Q3 | 120 Thousand USD | 50.0% |
| 2000 Q4 | 129.99 Thousand USD | 8.33% |
| 2000 Q1 | 69.99 Thousand USD | 0.0% |
| 1999 FY | 810 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | 91.771% |
| Arem Pacific Corporation | 367.08 Thousand USD | -1336.227% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -532.219% |
| BioCorRx Inc. | 3.84 Million USD | -37.26% |
| Bionik Laboratories Corp. | 5.81 Million USD | 9.335% |
| Banyan Corp. | 6.59 Million USD | 20.09% |
| Clearday, Inc. | 5 Million USD | -5.385% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -60.938% |
| Quantum Medical Transport, Inc. | 874.76 USD | -602591.367% |
| Empower Clinics Inc. | 6.92 Million USD | 23.839% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -116.033% |
| Selectis Health, Inc. | 14.36 Million USD | 63.305% |
| HealthLynked Corp. | 9.73 Million USD | 45.825% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | 44.145% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -684.949% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | 93.004% |
| MedSmart Group Inc. | 65.47 Thousand USD | -7952.577% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -579.609% |
| Nova Leap Health Corp. | 9.3 Million USD | 43.361% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -852.694% |
| PAO Group, Inc. | 45.42 Thousand USD | -11507.448% |
| Primemd Inc. | 6.25 Million USD | 15.753% |
| Raffles Medical Group Ltd | 151.69 Million USD | 96.524% |
| Ryman Healthcare Limited | 9.61 Million USD | 45.157% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -124447.673% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -281.823% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -754.856% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -589.164% |
| Veltex Corporation | 1.77 Million USD | -196.667% |
| World Financial Holding Group | 28.42 Thousand USD | -18446.764% |
| Xcelerate Inc. | 2.9 Million USD | -81.372% |